Genetic variants of the renin-angiotensin system and ambulatory blood pressure in essential hypertension

Journal of Hypertension

Volumn 15, Issue 5, 1997, Pages 503-508

  Beige, Joachim ^a   Zilch, Oliver ^a   Hohenbleicher, Henriette ^a   Ringel, Jens ^a   Kunz, Regina ^a   Distler, Armin ^a   Sharma, Arya M ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

Ambulatory blood pressure; Angiotensin converting enzyme; Angiotensinogen; Genetics; Hypertension; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGED; AMBULATORY MONITORING; ARTICLE; BLOOD PRESSURE MONITORING; DISEASE SEVERITY; ESSENTIAL HYPERTENSION; FEMALE; GENETIC VARIABILITY; GENOTYPE; GERMANY; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

EID: 0030925856     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715050-00005     Document Type: Article

References (44)

1. Ward R: Familial aggregation and genetic epidemiology of blood pressure. In Hypertension. Pathophysiology, Diagnosis, and Management. Edited by Laragh JH, Brenner BM. New York: Raven Press; 1990:81-100.
2. Lander ES, Schork NJ: Genetic dissection of complex traits. Science 1994, 265:2037-2048.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Litton RP, Williams CS, Chami A, et al.: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992, 71:169-180.
4. Jeunemaitre X, Chami A, Chatellier G, Dumont C, Sassano P, Soubrier F, et al.: M235T variant of the human angiotensinogen gene in unselected hypertensive patients. J Hypertens 1993, 11 (suppl 5):S80-S81.
5. Tiret L, Ricard S, Poirier O, Arveiler D, Cambou J-P, Luc G, Evans A, Nicaud V, Cambien F: Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM study. J Hypertens 1995, 13:311-317.
6. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, et al.: Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 1994, 93:1285-1287.
7. Iwai N, Shimoike H, Ohmichi N, Kinoshita M: Angiotensinogen gene and blood pressure in the Japanese population. Hypertension 1995, 25:688-693.
8. 235→Thr variant on blood pressure and other cardiovascular risk factors in two Japanese populations. J Hypertens 1995, 13:717-722.
9. Schmidt S, Sharma AM, Zilch O, Beige J, Walla Friedel M, Ganten D, et al.: Association of M235T variant of the angiotensinogen gene with familial hypertension of early onset. Nephrol Dial Transplant 1995. 10:1145-1148.
10. Rigat B, Hubert C, Alhenc Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990, 86:1343-1346.
11. Tiret L, Rigat B, Visvikis S, Breda C, Corvol P, Cambien F, et al.: Evidence, from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992. 51:197-205.
12. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, et al.: Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 1994, 330:1634-1638.
13. Cambien F, Poirier P, Lecerf L, Evans A, Cambou JP, Arveiler D, et al.: Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992. 359:641-644.
14. Markus HS, Barley J, Lunt R, Bland JM, Jeffery S, Carter ND, et al.: Angiotensinconverting enzyme gene deletion polymorphism: a new risk factor for lacunar stroke but not carotid atheroma. Stroke 1995, 26:1329-1333.
15. Anlauf M, Baumgart I, Franz I, Gotzen R, Krönig B, Meyer-Sabellek W, et al.: Empfehlungen der Deutschen Liga zur Bekämpfung der hohen Blutdruckes e.V.: Ambulante 24-h-Blutdruckmessung. Herz Kreislauf 1995, 27:III-VI.
16. Schiller NB, Shah PM, Crawford M, De Maria A, Devereux R, Feigenbaum H, et al.: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr 1989. 2:358-367.
17. Lindpaintner K, Pfeffer MA, Kreutz R, Stampfer MJ, Grodstein F, LaMotte F, et al.: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995, 332:706-711.
18. Rigat B, Hubert C, Corvol P, Soubrier F: PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP 1) (dipeptidyl carboxypeptidase 1). Nucleic Acids Res 1992, 20:1433.
19. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, et al.: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994, 330:1629-1633.
20. Rutledge DR, Browe CS, Kubilis PS, Ross EA: Analysis of two variants of the angiotensinogen gene in essential hypertensive African-Americans. Am J Hypertens 1994, 7:651-654.
21. Hegele RA, Brunt JH, Connelly PW: Genetic and biochemical factors associated with variation in blood pressure in a genetic isolate. Hypertension 1996, 27:308-312.
22. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, et al.: Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 1995, 96:687-692.
23. Staessen J, Fagard R, Lijnen P, Thijs L, van Hoof R, Amery A: Ambulatory blood pressure monitoring in clinical trials. J Hypertens 1991, 9 (suppl 9):S13-S19.
24. Pickering T: Recommendations for the use of home (self) and ambulatory blood pressure monitoring. Am J Hypertens 1996, 9: 1-11.
25. Fagard R, Staessen JA, Thijs L: The relationships between left ventricular mass and daytime and night-time blood pressures: a meta-analysis of comparative studies. J Hypertens 1995, 13:823-829.
26. James GD, Pickering TG, Yee LS, Harshfield GA, Riva S, Laragh JH: The reproducibility of average ambulatory, home, and clinic pressures. Hypertension 1988, 11:545-549.
27. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M, et al.: Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994, 24:793-801.
28. Somes GW, Harshfield GA, Alpert BS, Goble MM, Schieken RM: Genetic influences on ambulatory blood pressure patterns. The Medical College of Virginia Twin Study. Am J Hypertens 1995, 8:474-478.
29. Bennett CL, Schrader AP, Morris BJ: Cross-sectional analysis of Met234→Thr variant of angiotensinogen gene in severe, familial hypertension. Biochem Biophys Res Commun 1993, 197:833-839.
30. Rotimi C, Morrison L, Cooper R, Oyejide C, Effiong E, Ladipo M, et al.: Angiotensinogen gene in human hypertension: lack of an association of the 235T allele among African Americans. Hypertension 1994, 24:591-594.
31. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994, 90:2207-2212.
32. Zee RYL, Bennett CL, Schrader AP, Morris BJ: Frequencies of variants of candidate genes in different age groups of hypertensives. Clin Exp Pharmacol Physiol 1994, 21:925-930.
33. Wong KK, Summers KM, Burstow DJ, West MJ: Angiotensin-converting enzyme and angiotensinogen genes in patterns of left ventricular hypertrophy and in diastolic dysfunction. Clin Exp Pharmacol Physiol 1995, 22:438-440.
34. Yamakawa-Kobayashi K, Arinami T, Hamaguchi H: Absence of association of angiotensinogen gene T235 allele with increased risk of coronary heart disease in Japanese. Lancet 1995, 346:515.
35. Fornage M, Turner ST, Sing CF, Boerwinkle E: Variation at the M23 ST locus of the angiotensinogen gene and essential hypertension: a population-based case-control study from Rochester, Minnesota. Hum Genet 1995, 96:295-300.
36. Hingorani AD, Jia HY, Stevens PA, Hopper R, Dickerson JEC, Brown MJ: Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 1995, 13:1602-1609.
37. Ishigami T, Umemura S, Iwamoto T, Tamura K, Hibi K, Yamaguchi S, et al.: Molecular variant of angiotensinogen gene is associated with coronary atherosclerosis. Circulation 1995, 91:951-954.
38. Kamitani A, Rakugi H, Higaki J, Ohishi M, Shi S-J, Takami S, et al.: Enhanced predictability of myocardial infarction in Japanese by combined genotype analysis. Hypertension 1995, 25:950-953.
39. Summers KM, West JA, Huggard PR, West MJ: Angiotensin-converting enzyme and regulation of blood pressure in a large Australian family. Clin Exp Pharmacol Physiol 1993, 20:320-323.
40. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM: Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nature Genet 1992, 1:72-75.
41. Duru K, Farrow S, Wang J-M, Lockette W, Kurtz T: Frequency of a deletion polymorphism in the gene for angiotensin converting enzyme is increased in African-Americans with hypertension. Am J Hypertens 1994, 7:759-762.
42. Harrap SB, Davidson HR, Connor JM, Soubrier F, Corvol P, Fraser R, et al.: The angiotensin I converting enzyme gene and predisposition to high blood pressure. Hypertension 1993, 21:455-460.
43. Schmidt S, Van Hooft IMS, Grobbee DE, Ganten D, Ritz E: Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 1993, 11:345-348.
44. Lindpaintner K, Lee M, Larson MG, Rao VS, Rfeffer MA, Ordovas JM, et al.: Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med 1995, 92:2381-2384.